Pasithea Therapeutics Corp. (KTTAW) Total Current Liabilities (2020 - 2026)

Pasithea Therapeutics has disclosed Total Current Liabilities across 7 years of filings, most recently posting $1.8 million for Q2 2026.

• In Q2 2026, Total Current Liabilities rose 5.81% year-over-year to $1.8 million; the TTM figure through Jun 2026 stood at $1.8 million (up 5.81% YoY), while the FY2025 annual figure was $5.0 million, up 344.15% from the prior year.
• Total Current Liabilities came in at $1.8 million for Q2 2026 at Pasithea Therapeutics, up from $1.5 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $5.0 million in Q4 2025 to a low of $433684.0 in Q1 2022.
• Average Total Current Liabilities over 5 years is $1.8 million, with a median of $1.7 million recorded in 2025.
• Year-over-year, Total Current Liabilities jumped 389.33% in 2023 and plunged 67.69% in 2024.
• Over 5 years, Total Current Liabilities stood at $1.9 million in 2022, then soared by 40.29% to $2.6 million in 2023, then plunged by 57.48% to $1.1 million in 2024, then jumped by 344.15% to $5.0 million in 2025, then slumped by 63.05% to $1.8 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $1.8 million in Q2 2026, $1.5 million in Q1 2026, and $5.0 million in Q4 2025.